Curanex Pharmaceuticals Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.26-$9.18 |
Market Cap | $9.1M |
Shares Short | 50,975 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.02 |
News
See moreYahoo Finance • 11 days ago
CURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firm
Yahoo Finance • last month
Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
Yahoo Finance • last month
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
Yahoo Finance • 2 months ago
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
About
CEO | Mr. Jun Liu |
CFO | Ms. Haiyan Yang |
Address | 2 Jericho Plaza, Jericho, NY, United States, 11753 |
Sector | Healthcare |
Industry | Biotechnology |